1. Acknowledgement to Referees

   Acknowledgement to Referees 08 January 2024 Pages: 1 - 4

2. Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic

   • Jonathan K. Hwang
   • Natalia Pelet del Toro
   • Shari R. Lipner

   Leading Article 07 December 2023 Pages: 5 - 14

3. Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments

   • Svenja Müller
   • Claudia Zeidler
   • Sonja Ständer

   Review Article Open access 17 September 2023 Pages: 15 - 33

   

4. Oral Lichen Planus: An Update on Diagnosis and Management

   • Agathe Louisy
   • Eiryann Humbert
   • Mahtab Samimi

   Review Article 15 September 2023 Pages: 35 - 53

   

5. Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives

   • Mónica Munera-Campos
   • Jose Manuel Carrascosa

   Review Article 30 October 2023 Pages: 55 - 66

   

6. What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus

   • Georgia Biazus Soares
   • Joan Guitart
   • Gil Yosipovitch

   Review Article 16 November 2023 Pages: 67 - 77

   

7. Non-invasive Skin Imaging in Cutaneous Lymphomas

   • Eyal Taleb
   • Oriol Yélamos
   • Shamir Geller

   Review Article 14 November 2023 Pages: 79 - 89

   

8. Treat-to-Target in Atopic Dermatitis

   • Christian Vestergaard
   • Catalina Skovsgaard
   • Jacob P. Thyssen

   Review Article 11 December 2023 Pages: 91 - 98

   

9. Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy

   • Maggie Chen
   • Albert Zhou
   • Amor Khachemoune

   Review Article 02 December 2023 Pages: 99 - 118

   

10. Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma

    • Alexis G. Strahan
    • Ivan Švagelj
    • Drazen Jukic

    Original Research Article 04 September 2023 Pages: 119 - 126

    

11. Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2

    • Gil Yosipovitch
    • Melinda J. Gooderham
    • Daniela E. Myers

    Original Research Article Open access 25 August 2023 Pages: 127 - 138

    

12. Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1

    • Eric L. Simpson
    • Andrew Blauvelt
    • Andreas Wollenberg

    Original Research Article Open access 07 October 2023 Pages: 139 - 148

    

13. AtopyReg^®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

    • Luca Stingeni
    • Andrea Chiricozzi
    • AtopyReg® study group

    Original Research Article Open access 19 September 2023 Pages: 149 - 160

    

14. Correction to: AtopyReg^®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

    • Luca Stingeni
    • Andrea Chiricozzi
    • AtopyReg® study group

    Correction Open access 07 November 2023 Pages: 161 - 161

15. Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids

    • Jonathan I. Silverberg
    • April Armstrong
    • Kristian Reich

    Correction Open access 27 November 2023 Pages: 163 - 163

16. Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

    • Tadashi Terui
    • Yukari Okubo
    • Masamoto Murakami

    Author Correction Open access 07 December 2023 Pages: 165 - 167